LHV finantsportaal

Foorum Investeerimine

Börsipäev 27. september

Kommentaari jätmiseks loo konto või logi sisse

  • Müügisurve jätkus esmaspäeval läbi terve päeva, kui turuosalised jäid ootama USA presidendikandidaatide esimest debatti ning finantssektorit mõjutas negatiivselt Deutsche Banki aktsia -7,5% kukkumine madalaimale tasemele alates 1983.a. S&P 500 sulgus -0,9% kaotusega ning toetust ei suutnud pakkuda isegi energiasektor vaatamata nafta 3,3% kallinemisele, mida ajendas Saudi Araabia pakkumine vähendada oma naftatootmist jaanuari tasemele juhul kui Iraan oma tootmise kasvu külmutab.

    Olgugi et eile avaldatud Saksamaa ettevõtete kindlustunde indeksite oodatust tugevam põrge septembris aitas riigi majandusest maalida positiivsema pildi võrreldes PMI küsitlusega, keskendusid turuosalised Dutsche Banki ümber toimuvale, mis tiris allapoole ka ülejäänud finantssektorit ning jättis Stoxx 600 indeksi -1,6% punasesse. Deutsche Bank seisab silmits 14 miljardi dollari suuruse trahviga, mida USA valitsus nõuab hüpoteeklaenudega seotud väärtpaberite ebakorrektse müügipraktika tõttu. Viimase sõnul on pank fundamentaalselt tugev, kuid paratamatult küsivad paljud, kas trahvisumma maksmine võiks käia üle jõu ning vaja läheb uut kapitali, potentsiaalselt isegi valitsuselt.

    USA uute majade müük alanes augustis küll kuiselt -7,6% võrra, kuid langus osutus väiksemaks võrreldes analüütikute -8,3% ootusega ning tuli pärast ebatavaliselt suurt hüpet juulis (13,8%), mil annualiseeritud müük jõudis kõrgeimale tasemele alates 2008.a. Aastatagusega võrreldes müüdi uusi majasid augustis 20,6% rohkem ning üsna tugevale trendile viitab ka selle aasta esimese kaheksa kuu müük, mis on ületanud mullust tulemust 13,3%.

    Aasias alustasid aktsiaturud sessiooni samuti madalamal, kuid on kirjutamise hetkeks roninud tagasi plusspoolele ning positiivsemates meeleoludes liiguvad ka USA aktsiaindeksite futuurid (ES +0,6%). Tänastest majandusuudistest võiksid suurimat tähelepanu pälvida USA teenindussektori septembrikuu esialgne aktiivsusindeks ning USA tarbijate septembri kindlustunde indeks.

    11.00 Itaalia tööstustoodangu müük ja tellimused (juuli)
    11.00 Eurotsooni rahapakkumise statistika (august)
    16.00 USA Case-Shilleri 20 linna majade hinnaindeks (juuli)
    16.45 USA Markiti teenindussektori PMI (september)
    17.00 USA tarbijate kindlustunde indeks (september)
    17.00 USA Richmond FEDi töötleva tööstuse küsitlus (september)
  • Eurotsooni majapidamistele väljastatud laenude kasv püsis augustis 1,7% peal, ärilaenud väljaspool finantssektorit kasvasid YoY 1,9%, mis ühtis samuti juulikuu tempoga
  • Gapping up
    In reaction to strong earnings/guidance
    : SNX +7.8%, ( also increased quarterly cash dividend), THO +1.3%

    M&A news:
    GI +88.9% (to be acquired by Boston Scientific (BSX) for $8.00/share)
    RMP +2.8% (ticking higher, will purchase the acquired midstream assets from Rice Energy for $600 mln. The transaction is expected to close in the fourth quarter of 2016, subject to customary closing conditions)
    Other news:
    INFI +12.4% (presents new preclinical data for IPI-549 that "appear favorable")
    KITE +11.9% (announces positive topline KTE-C19 data from ZUMA-1 pivotal trial in patients with aggressive non-hodgkin lymphoma (NHL) -- Study met primary endpoint with combined complete response rate of 39% at three months)
    ARRY +11.2% (cont strength)
    PPHM +10.2% (presentation of preclinical study data demonstrating that PS-targeting antibodies similar to bavituximab)
    PIRS +10.1% (Pieris Pharmaceuticals presents 'positive' data for its bispecific drug candidate, PRS-343)
    NYRT +8.2% (files for 3,452,7 share common stock offering by selling shareholders; retains Spencer Stuart for independent Board Of Directors candidate search)
    PERI +8% (CEO to step down; Directors to begin search for new CEO)
    JUNO +6.7% (following KITE's CAR-T data)
    DNAI +5.9% (obtains an exclusive license from the CRT Pioneer Fund LP for worldwide rights to develop and commercialize PNT737)
    ATNM +5% (initiates a Phase 2 clinical trial of Actimab-A in patients newly diagnosed with Acute Myeloid Leukemia who are over the age of 60)
    BLDP +4.9% (announces that automotive OEM Audi AG has issued purchase orders to accelerate certain key development activities)
    HEAR +4.3% (light volume, restructuring Hypersound business to substantially lower operating costs)
    NAVB +4.1% (appoints Michael Goldberg, M.D. President and Chief Executive Officer and Eric Rowinsky, M.D. as Chairman)
    PTIE +3.8% (after Monday's 50% decline on CRL news)
    DRRX +2.6% (after Monday's 30%+ decline on CRL news)
    AGRO +2.4% (Adecoagro S.A. extends share repurchase program for and additional twelve-month period ending on September 23, 2017)
    TRIL +1.3% (presents data indicating TTI-621 signal leads to enhanced anti-tumor CD8 + T cell responses)
    NQ +1% (announces Zhongzhi Hitech Overseas Investment agreed to purchase $220 mln convertible notes through a private placement)
    Analyst comments:
    ORAN +2.2% (upgraded to Outperform from Neutral at Credit Suisse)
    LLY +1.5% (upgraded to Buy from Neutral at Goldman)
    AZO +1.2% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
    AMZN +0.6% (target raised to $1000 from $925 at JP Morgan)
    CBOE +0.6% (upgraded to Neutral from Underperform at Credit Suisse)
    Gapping down
    In reaction to disappointing earnings/guidance:
    FDS -0.7%

    M&A news:
    SXL -8.2% (to acquire Vitol's crude platform for about $760 mln plus working capital; commenced an underwritten public offering of 21 mln common units pursuant to an effective shelf registration statement on Form S-3 previously filed with the SEC)
    RICE -6% (to acquire Vantage Energy for approximately $2.7 billion; commences a 40 mln share underwritten public offering of common stock)
    MPW -3.9% (to acquire the real estate interests of nine acute care hospitals operated by Steward Health Care System; commences 33.5 mln common stock offering)
    Select EU financial related names showing weakness: CS -3.4%, DB -3%, RBS -2.6%, BCS -1.3%

    Select oil/gas related names showing early weakness: MRO -2.5%, WLL -2.5%, CHK -2.1%, OAS -1.9%, RIG -1.8%, RDS.A -1.2%

    Other news:
    CVM -44.4% (receives FDA notice that its Multikine Phase 3 trial placed on clinical holdg)
    MIME -8.7% (commences a registered secondary public offering of 4 mln ordinary shares by selling shareholders)
    CZR -7.5% (announce proposed consensual restructuring plan for CEOC)
    NAT -7.1% (announced an underwritten public offering of 11 mln common shares)
    MYOK -3.7% (announces underwritten public offering of 3,800,000 shares of its common stock)
    AMGN -2.1% (reports Phase 3 KYPROLIS; trial did not meet the primary endpoint)
    Analyst comments:
    GILD -1.4% (downgraded to Mkt Perform from Outperform at Leerink Partners)
    DLTR -0.9% (downgraded to Underweight from Neutral at Atlantic Equities)
    CRI -0.8% (downgraded to Market Perform from Outperform at Wells Fargo)
    SJM -0.5% (downgraded to Neutral from Outperform at Credit Suisse)

    Briefing.com
  • USA teenindussektori aktiivsus paranes Markiti küsitluse kohaselt septembris 0,9 punkti 51,9 punktile, osutudes oodatud 51,1st paremaks. Negatiivsest aspektist jätkus uute tellimuste pealevoolu aeglustumine ning tööhõivet mõõtev indeks langes 3,5a madalaimale tasemele.

  • USA tarbijate kindlustunde indeks on teinud tubli taastumise ning jõudis septembris kõrgeimale tasemele alates 2007.a. Richmondi töötlevas tööstuses jätkub aktiivsuse kahanemine.

    US Consumer Confidence Index Sep: 104.1 (est 99; prev 100.1)
    Richmond Fed’s Sept. Manufacturing Survey at -8 vs Est. -2

Teemade nimekirja